1 year return (CAGR)
-52.22%
Cellectis SA Exchange (NASDAQ, USD)
CLLS
1.51
-0.02 (-1.31%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-4.06%
5 year return (CAGR)
-36.21%
10 year return (CAGR)
-24.57%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
109.78M
Price/Sales
1.94
Ent value
300.49M
Price/Book
2.67
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-18.70%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.53 |
| Daily high | 1.55 |
| Daily low | 1.46 |
| Daily Volume | 89K |
| All-time high | 47.66 |
| 1y analyst estimate | 7.60 |
| Beta | 2.77 |
| EPS (TTM) | -0.65 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 11 Mar 2026 |
Downside potential
Loading...
Downside potential data
| CLLS | S&P500 | |
| Current price drop from All-time high | -96.83% | -0.56% |
| Highest price drop | -97.96% | -56.47% |
| Date of highest drop | 31 Oct 2023 | 9 Mar 2009 |
| Avg drop from high | -69.48% | -10.68% |
| Avg time to new high | 722 days | 12 days |
| Max time to new high | 2846 days | 1805 days |
News
